➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

BLINCYTO Drug Profile

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for Tradename: BLINCYTO

Patents:	22
Applicants:	1
BLAs:	1
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for BLINCYTO

Recent Clinical Trials for BLINCYTO

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
University of California, San Francisco	Phase 2
French Innovative Leukemia Organisation	Phase 2
Novartis Pharmaceuticals	Phase 3

See all BLINCYTO clinical trials

Company Disclosures: US Patents for BLINCYTO

These patents were extracted from company disclosures

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Amgen	BLINCYTO	blinatumomab	INJECTABLE;INJECTION	125557	001	2014-12-03	Start Trial	Micromet AG (Munich, DE)	2018-04-21	RX	Orphan	company
Amgen	BLINCYTO	blinatumomab	INJECTABLE;INJECTION	125557	001	2014-12-03	Start Trial	Micromet AG (Munich, DE)	2018-04-21	RX	Orphan	company
Amgen	BLINCYTO	blinatumomab	INJECTABLE;INJECTION	125557	001	2014-12-03	Start Trial	Micromet AG (Munich, DE)	2025-12-16	RX	Orphan	company
Amgen	BLINCYTO	blinatumomab	INJECTABLE;INJECTION	125557	001	2014-12-03	Start Trial	Micromet AG (Munich, DE)	2029-10-27	RX	Orphan	company
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

Patent Text Search: US Patents for BLINCYTO

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Amgen	BLINCYTO	blinatumomab	INJECTABLE;INJECTION	125557	001	2014-12-03	Start Trial	AbbVie Stemcentrx LLC (North Chicago, IL)	2033-02-08	RX	Orphan	search
Amgen	BLINCYTO	blinatumomab	INJECTABLE;INJECTION	125557	001	2014-12-03	Start Trial	Advenchen Pharmaceuticals, LLC (Moorpark, CA)	2035-05-04	RX	Orphan	search
Amgen	BLINCYTO	blinatumomab	INJECTABLE;INJECTION	125557	001	2014-12-03	Start Trial	CureVac AG (Tubingen, DE)	2032-02-15	RX	Orphan	search
Amgen	BLINCYTO	blinatumomab	INJECTABLE;INJECTION	125557	001	2014-12-03	Start Trial	Cipla Limited (Mumbai, IN)	2036-06-30	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for BLINCYTO

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Poland	344016	Start Trial
Australia	2006326727	Start Trial
European Patent Office	2954056	Start Trial
South Korea	101841781	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow

Harvard Business School

Boehringer Ingelheim

Colorcon

AstraZeneca

McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.